Amanote Research
Register
Sign In
Efficacy of Atenolol and Captopril in Reducing Risk of Macrovascular and Microvascular Complications in Type 2 Diabetes: UKPDS 39
BMJ
doi 10.1136/bmj.317.7160.713
Full Text
Open PDF
Abstract
Available in
full text
Date
September 12, 1998
Authors
Unknown
Publisher
BMJ
Related search
Microvascular and Macrovascular Complications in Children and Adolescents With Type 1 Diabetes
Serum 25-Hydroxyvitamin D: A Predictor of Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Pdb10 - Macrovascular and Microvascular Complications of Type 2 Diabetes Mellitus and Its Associated Frequency of Hospital Admission
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Diabetes in Utah Among Adults: Interaction Between Diabetes and Other Risk Factors for Microvascular and Macrovascular Complications.
American Journal of Public Health
Environmental
Public Health
Occupational Health
Impact of Normoglycemia in Reducing Microvascular Complications in Patients With Type 2 Diabetes: A Follow-Up Study
Frontiers in Endocrinology
Endocrinology
Metabolism
Diabetes
Pharmacoeconomic Analysis of Type 2 Diabetes Mellitus and Its Microvascular Complications
International Journal of Research in Hospital and Clinical Pharmacy
A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data From the Diabetes Control and Complications Trial
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Alcohol Consumption and Risk of Microvascular Complications in Type 1 Diabetes Patients: The EURODIAB Prospective Complications Study
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
